Catheter Precision, Inc.
VTAK · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -5% | 3,057.1% | -36.4% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $2 |
| Gross Profit | $0 | $0 | -$0 | -$2 |
| % Margin | 90% | 93.2% | -1,050% | -6,990.9% |
| R&D Expenses | $0 | $0 | $6 | $12 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $11 | $17 | $16 | $15 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $61 | $4 | $0 |
| Operating Expenses | $12 | $79 | $27 | $28 |
| Operating Income | -$11 | -$78 | -$27 | -$29 |
| % Margin | -2,676.9% | -17,674% | -192,578.6% | -133,027.3% |
| Other Income/Exp. Net | -$2 | $8 | $0 | $2 |
| Pre-Tax Income | -$14 | -$71 | -$27 | -$27 |
| Tax Expense | $3 | $0 | $0 | $0 |
| Net Income | -$17 | -$71 | -$27 | -$25 |
| % Margin | -3,962.6% | -15,966.5% | -191,892.9% | -113,954.5% |
| EPS | -6.68 | -12.99 | -25.98 | -248.22 |
| % Growth | 48.6% | 50% | 89.5% | – |
| EPS Diluted | -6.68 | -12.99 | -25.98 | -248.22 |
| Weighted Avg Shares Out | 3 | 5 | 1 | 0 |
| Weighted Avg Shares Out Dil | 3 | 5 | 1 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $2 | $2 | $0 | $1 |
| EBITDA | -$11 | -$15 | -$22 | -$26 |
| % Margin | -2,691% | -3,418.6% | -159,771.4% | -117,486.4% |